CVS Health Q4 2019 Earnings Report
Key Takeaways
CVS Health's Q4 2019 revenues increased by 22.9% to $66.9 billion, GAAP operating income increased to $3.0 billion, and adjusted operating income increased by 1.3% to $3.8 billion. GAAP diluted earnings per share from continuing operations were $1.33, and adjusted EPS was $1.73. The company's performance reflects strong financial and operational execution and a successful first year of integrating the Aetna business.
Total revenues increased 22.9% to $66.9 billion.
GAAP operating income increased to $3.0 billion.
Adjusted operating income increased 1.3% to $3.8 billion.
GAAP diluted earnings per share from continuing operations of $1.33, with Adjusted EPS of $1.73.
CVS Health
CVS Health
CVS Health Revenue by Segment
Forward Guidance
The Company’s full year 2020 consolidated GAAP operating income is projected to be in the range of $12.8 billion to $13.0 billion and full year 2020 adjusted operating income is projected to be in the range of $15.5 billion to $15.8 billion. Full year 2020 GAAP diluted EPS from continuing operations is projected to be in the range of $5.47 to $5.60, and full year 2020 Adjusted EPS is projected to be in the range of $7.04 to $7.17.
Positive Outlook
- GAAP operating income in the range of $12.8 billion to $13.0 billion
- Adjusted operating income in the range of $15.5 billion to $15.8 billion
- GAAP diluted EPS from continuing operations in the range of $5.47 to $5.60
- Adjusted EPS in the range of $7.04 to $7.17
- Cash flow from operations in the range of $10.5 billion to $11.0 billion
Revenue & Expenses
Visualization of income flow from segment revenue to net income